title: Microchimerism and blocking activity in women with recurrent spontaneous abortion (RSA) after alloimmunization with the partner's lymphocytes.
abstract: Alloimmunization therapy using the partner's leukocytes has been reported to be effective in preventing the failure of pregnancy in patients who have suffered RSA of unknown cause. After alloimmunization, several investigators have reported the presence of blocking factors (BF) in women with successful pregnancies in in vitro assays of lymphocyte response. The recent discovery of small numbers of ubiquitous donor cells (microchimerism) in human transplants up to 29 years post-transplantation has raised questions about the migration of the chimeric cells and their role in the induction and perpetuation of tolerance. We have investigated the production of BF in the mixed lymphocyte reaction (MLR) before and in some patients after alloimmunization and its possible relation with the development of microchimerism (M). Before the treatment we studied 14 couples with three or more abortions who were evaluated clinically to rule-out genetic, structural, endocrine, infectious and autoimmune causes. The M study was done by nested PCR-SSP technique with HLA-DR alleles, before and after 30 days of the last immunization. Before the treatment only one patient was M positive and none were BF positive with inhibition effect (IE) > 50. Only eight underwent treatment. The patients had between three and nine alloimmunizations (x = 4.7). After treatment, all patients were M positive with IE > 50. Six months after the last immunization, four patients are M positive with IE > 50. In conclusion, the hypothesis proposes that alloimmunization establishes a state of microchimerism that would be the necessary allogeneic stimulus for T-cell activation, and the induction or maintenance of tolerance to the fetus during pregnancy. reserved.
authors.affiliation: Diagnostic Department, Hospital Italiano de Buenos Aires, Argentina. hcomp@hitalba.edu.ar
authors.forename: N
authors.initials: N
authors.lastname: Prigoshin
authors.forename: M L
authors.initials: ML
authors.lastname: Tambutti
authors.forename: M A
authors.initials: MA
authors.lastname: Redal
authors.forename: S
authors.initials: S
authors.lastname: Gorgorza
authors.forename: S M
authors.initials: SM
authors.lastname: Lancuba
authors.forename: R
authors.initials: R
authors.lastname: Nicholson
authors.forename: R
authors.initials: R
authors.lastname: Testa
mesh_terms: D000026:Abortion, Habitual / Q000276:immunology*; D000328:Adult; D005260:Female; D006684:HLA-DR Antigens / Q000276:immunology; D006801:Humans; D007114:Immunization; D017710:Lymphocyte Transfusion; D008214:Lymphocytes / Q000276:immunology*; D008297:Male; D011247:Pregnancy; D018454:Spouses
chemical_list: D006684:HLA-DR Antigens